DABIGATRAN ETEXILATE 75 MG CAP

DABIGATRAN ETEXILATE
$0.8478per EA

Strength

75 mg/1

NDC

59651097360

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA208039

On Market Since

5/14/2025

Pharmacological Classes

Direct Thrombin Inhibitor
Thrombin Inhibitors

Price History

1W

0.0%

1M

-10.0%

3M

-19.6%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-22.4%